Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Alemtuzumab/probenecid

Autoimmune haemolytic anaemia and pure red cell aplasia: case report

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Kako S, Kanda Y, Oshima K, Nishimoto N, Sato H, Watanabe T, Hosoya N, Motokura T, Miyakoshi S, Taniguchi S, Kamijo A, Takahashi K, Chiba S, Kurokawa M.Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab. American Journal of Hematology 83: 247-249, No. 3, Mar 2008 - Japan

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Alemtuzumab/probenecid. React. Wkly. 1197, 5 (2008). https://doi.org/10.2165/00128415-200811970-00012

    Download citation

    Keywords

    • Alemtuzumab
    • Probenecid
    • Cidofovir
    • Haematopoietic Stem Cell Transplantation
    • Reticulocyte Count